B Complex vs Modafinil for energy
Short answer: For energy, users rate them about the same: 95% report improvement with B Complex (93 reports) and 93% with Modafinil (485 reports).
B Complex has 246 meta-analyses and 106 randomized trials on PubMed; Modafinil has 155 and 297.
Based on 572 reports about B Complex and 1,613 about Modafinil. Not medical advice.
| B Complex Supplement | Modafinil Medication | |
|---|---|---|
| Users say it helped | 66%helped166 reports · high confidence | 50%helped936 reports · high confidence |
| Verdict | Mostly positive | Mixed |
| Research | AResearch: Strong | AResearch: Strong |
| Meta-analyses / RCTs | 246 / 106 | 155 / 297 |
| Mainly used for | ||
| Focus % reporting improvement | 84% (25) | 86% (689) |
| Energy % reporting improvement | 95% (93) | 93% (485) |
| Mood % reporting improvement | 91% (35) | 64% (125) |
| Anxiety % reporting improvement | 43% (23) | 30% (87) |
| Sleep % reporting improvement | 64% (11) | 21% (94) |
| Common side effects | anxiety, insomnia, headache, neuropathy | insomnia, anxiety, headache, tolerance |
| Typical dose reported | 500 mcg B12 | Not listed |
This meta-analysis suggests that B vitamin supplementation is associated with slowing of cognitive decline, especially in populations who received early intervention and intervention of long duration; the study also indicates that higher intake of dietary folate, but not B12 or B6, is associated with a reduced risk of incident dementia in non-dementia aged population. Given the prevalence of dementia cases in many countries with aging populations, public health policies should be introduced to ensure that subgroups of the population at risk have an adequate B vitamin status.
Nutr Rev, 2022 ↗“Adding a B complex has totally eliminated my depression lethargy brain fog insomnia and anxiety.”
Our findings represent the most comprehensive available evidence base to inform patients, families, clinicians, guideline developers, and policymakers on the choice of ADHD medications across age groups. Taking into account both efficacy and safety, evidence from this meta-analysis supports methylphenidate in children and adolescents, and amphetamines in adults, as preferred first-choice medications for the short-term treatment of ADHD. New research should be funded urgently to assess long-term effects of these drugs.
Lancet Psychiatry, 2018 ↗“It did make me focused and alert. I was working two jobs at the time and needed every ounce of energy I could muster.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate